中药龙头业绩比拼!白云山、云南白药、华润三九、同仁堂

赛柏蓝
Sep 02, 2025

2025H1实现百亿营收的有白云山、云南白药、华润三九,同仁堂逼近百亿门槛。四家药企营收均实现正增长,但“增收不增利”现象凸显白云山以418.35亿元的营收居首,增速1.93%;云南白药和华润三九营收分别为212.57亿元和148.10亿元,同比增长3.92%、4.99%;同仁堂营收97.69亿元,几乎与去年同期持平,微增0.06%。利润方面,仅云南白药实现同比13.93%的正增长,归母净利润...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10